134 related articles for article (PubMed ID: 34358720)
1. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
[TBL] [Abstract][Full Text] [Related]
2. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
Tan PS; Garriga C; Clift A; Liao W; Patone M; Coupland C; Bashford-Rogers R; Sivakumar S; Hippisley-Cox J
Gut; 2023 Mar; 72(3):512-521. PubMed ID: 35760494
[TBL] [Abstract][Full Text] [Related]
3. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
[TBL] [Abstract][Full Text] [Related]
4. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
5. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
6. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.
Sharma A; Smyrk TC; Levy MJ; Topazian MA; Chari ST
Gastroenterology; 2018 Aug; 155(2):490-500.e2. PubMed ID: 29723506
[TBL] [Abstract][Full Text] [Related]
7. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
Lemanska A; Price CA; Jeffreys N; Byford R; Dambha-Miller H; Fan X; Hinton W; Otter S; Rice R; Stunt A; Whyte MB; Faithfull S; de Lusignan S
PLoS One; 2022; 17(10):e0275369. PubMed ID: 36197912
[TBL] [Abstract][Full Text] [Related]
8. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
[TBL] [Abstract][Full Text] [Related]
9. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
Gomez-Rubio P; Rosato V; Márquez M; Bosetti C; Molina-Montes E; Rava M; Piñero J; Michalski CW; Farré A; Molero X; Löhr M; Ilzarbe L; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Domínguez-Muñoz E; Gutiérrez-Sacristán A; Balsells J; Costello E; Guillén-Ponce C; Huang J; Iglesias M; Kleeff J; Kong B; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Lawlor RT; Carrato A; Hidalgo M; Scarpa A; Sharp L; Furlong LI; Real FX; La Vecchia C; Malats N;
Ann Oncol; 2017 Jul; 28(7):1618-1624. PubMed ID: 28383714
[TBL] [Abstract][Full Text] [Related]
10. The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study.
Mueller AM; Meier CR; Jick SS; Schneider C
Pancreas; 2018 Aug; 47(7):807-815. PubMed ID: 29975346
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
[TBL] [Abstract][Full Text] [Related]
12. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
13. Weight Loss as an Untapped Early Detection Marker in Pancreatic and Periampullary Cancer.
Hue JJ; Sugumar K; Kyasaram RK; Shanahan J; Lyons J; Ocuin LM; Rothermel LD; Hardacre JM; Ammori JB; Rao G; Winter JM; Markt SC
Ann Surg Oncol; 2021 Oct; 28(11):6283-6292. PubMed ID: 33835301
[TBL] [Abstract][Full Text] [Related]
14. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
15. New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population.
Huang BZ; Pandol SJ; Jeon CY; Chari ST; Sugar CA; Chao CR; Zhang ZF; Wu BU; Setiawan VW
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1812-1821.e7. PubMed ID: 31809917
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study.
Saeed U; Myklebust TÅ; Robsahm TE; Møller B; Mala T; Skålhegg BS; Yaqub S
Scand J Surg; 2023 Mar; 112(1):11-21. PubMed ID: 36173093
[TBL] [Abstract][Full Text] [Related]
18. Gynecological and reproductive factors and the risk of pancreatic cancer: A case-control study.
Archibugi L; Graglia B; Valente R; Stigliano S; Roberto M; Capalbo C; Marchetti P; Nigri G; Capurso G
Pancreatology; 2020 Sep; 20(6):1149-1154. PubMed ID: 32800645
[TBL] [Abstract][Full Text] [Related]
19. Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study.
Jensen MH; Cichosz SL; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
Pancreatology; 2023 Sep; 23(6):642-649. PubMed ID: 37422338
[TBL] [Abstract][Full Text] [Related]
20. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
